carbamazepine has been researched along with Chondrodystrophic Myotonia in 8 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Carbamazepine was used as an anti-myotonic agent in three cases with the Schwartz-Jampel syndrome." | 5.29 | Improvement of myotonia with carbamazepine in three cases with the Schwartz-Jampel syndrome. ( Gücüyener, K; Okan, M; Serdaroğlu, A; Topaloğlu, H; Topçu, M, 1993) |
| "Oral carbamazepine therapy was initiated and 1." | 1.51 | Schwartz Jampel syndrome responding positively to carbamazepine therapy: a case report and a novel mutation. ( Albayrak, HM; Gürbüz, G, 2019) |
| "We report an infant with moyamoya disease and recurrent stroke presenting 10 months after diagnosis (at age 18 months), and discuss the outcome of nonsurgical medical management." | 1.38 | Medical management of moyamoya disease and recurrent stroke in an infant with Majewski osteodysplastic primordial dwarfism type II (MOPD II). ( Alanay, Y; Boduroğlu, K; Cetin, M; Haliloğlu, G; Kılıç, E; Oğuz, KK; Unal, S; Utine, E, 2012) |
| "Carbamazepine was used as an anti-myotonic agent in three cases with the Schwartz-Jampel syndrome." | 1.29 | Improvement of myotonia with carbamazepine in three cases with the Schwartz-Jampel syndrome. ( Gücüyener, K; Okan, M; Serdaroğlu, A; Topaloğlu, H; Topçu, M, 1993) |
| "Treatment with carbamazepine, initiated at age 7 months (corrected age of 5 months) has produced marked and continued resolution of myotonia, lessened malformation of her bell-shaped chest, and developmental progress." | 1.29 | Neonatal diagnosis of Schwartz-Jampel syndrome with dramatic response to carbamazepine. ( Prangley, J; Squires, LA, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gürbüz, G | 1 |
| Albayrak, HM | 1 |
| Forouhan, M | 1 |
| Sonntag, S | 1 |
| Boot-Handford, RP | 1 |
| Dai, L | 1 |
| Fang, F | 1 |
| Huang, Y | 1 |
| Cheng, H | 1 |
| Ren, C | 1 |
| Kılıç, E | 1 |
| Utine, E | 1 |
| Unal, S | 1 |
| Haliloğlu, G | 1 |
| Oğuz, KK | 1 |
| Cetin, M | 1 |
| Boduroğlu, K | 1 |
| Alanay, Y | 1 |
| Reed, UC | 1 |
| Reimao, R | 1 |
| Espindola, AA | 1 |
| Kok, F | 1 |
| Ferreira, LG | 1 |
| Resende, MB | 1 |
| Messias, TC | 1 |
| Carvalho, MS | 1 |
| Diament, A | 1 |
| Scaff, M | 1 |
| Marie, SK | 1 |
| Ho, NC | 1 |
| Sandusky, S | 1 |
| Madike, V | 1 |
| Francomano, CA | 1 |
| Dalakas, MC | 1 |
| Topaloğlu, H | 1 |
| Serdaroğlu, A | 1 |
| Okan, M | 1 |
| Gücüyener, K | 1 |
| Topçu, M | 1 |
| Squires, LA | 1 |
| Prangley, J | 1 |
1 review available for carbamazepine and Chondrodystrophic Myotonia
| Article | Year |
|---|---|
[Clinical and genetic features of Schwartz-Jampel syndrome in a Chinese child: case report and literature review].
Topics: Asian People; Carbamazepine; Child; Child, Preschool; Exons; Female; Heterozygote; Humans; Infant; I | 2015 |
7 other studies available for carbamazepine and Chondrodystrophic Myotonia
| Article | Year |
|---|---|
Schwartz Jampel syndrome responding positively to carbamazepine therapy: a case report and a novel mutation.
Topics: Anticonvulsants; Carbamazepine; Child, Preschool; DNA; DNA Mutational Analysis; Female; Heparan Sulf | 2019 |
Carbamazepine reduces disease severity in a mouse model of metaphyseal chondrodysplasia type Schmid caused by a premature stop codon (Y632X) in the Col10a1 gene.
Topics: Animals; Carbamazepine; Chondrocytes; Codon, Nonsense; Collagen Type X; Disease Models, Animal; Endo | 2018 |
Medical management of moyamoya disease and recurrent stroke in an infant with Majewski osteodysplastic primordial dwarfism type II (MOPD II).
Topics: Antigens; Carbamazepine; Dwarfism; Female; Fetal Growth Retardation; Heparin, Low-Molecular-Weight; | 2012 |
Schwartz-Jampel syndrome: report of five cases.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Female; Follow-Up Studies; Humans; Infant; Male; | 2002 |
Clinico-pathogenetic findings and management of chondrodystrophic myotonia (Schwartz-Jampel syndrome): a case report.
Topics: Abnormalities, Multiple; Alleles; Alternative Splicing; Carbamazepine; Child; DNA Mutational Analysi | 2003 |
Improvement of myotonia with carbamazepine in three cases with the Schwartz-Jampel syndrome.
Topics: Blepharospasm; Carbamazepine; Child; Child, Preschool; Female; Humans; Locomotion; Male; Myotonia; N | 1993 |
Neonatal diagnosis of Schwartz-Jampel syndrome with dramatic response to carbamazepine.
Topics: Anticonvulsants; Carbamazepine; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Infant, | 1996 |